MARC Record from marc_columbia

LEADER: 03928cam a2200421Ii 4500
001 10293147
005 20140922152514.0
008 130531s2013 dcuab b 000 0 eng d
010 $a 2013444244
019 $a852221106$a854310128
020 $a9780309282826
020 $a0309282829
035 $a(OCoLC)852134547$z(OCoLC)852221106$z(OCoLC)854310128
035 $a(OCoLC)ocn852134547
035 $a(NNC)10293147
040 $aNRC$beng$erda$cNRC$dNRC$dNTD$dCDX$dIXA$dBTCTA$dCUT$dDLC
043 $an-us---
050 4 $aRA412.3$b.I565 2013
060 4 $aWT 31
082 04 $a368.42600973$222
110 2 $aInstitute of Medicine (U.S.).$bCommittee on Geographic Variation in Health Care Spending and Promotion of High-Value Care,$eauthor.
245 10 $aInterim report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care :$bpreliminary committee observations /$cCommittee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, Board on Health Care Services ; Joseph P. Newhouse [and five others], editors ; Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bNational Academies Press,$c[2013]
300 $axiii, 39 pages :$billustrations (some color), maps (some color),$c28 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
520 $a"Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care: Preliminary Committee Observations is designed to provide the committee's preliminary observations for the 113th Congress as it considers further Medicare reform. This report contains only key preliminary observations related primarily to the committee's commissioned analyses of Medicare Parts A (Hospital Insurance program), B (Supplementary Medical Insurance program) and D (outpatient prescription drug benefit), complemented by other empirical investigations. It does not contain any observations related to the committee's commissioned analyses of the commercial insurer population, Medicare Advantage, or Medicaid, which will be presented in the committee's final report after completion of quality-control activities. This interim report excludes conclusions or recommendations related to the committee's consideration of the geographic value index or other payment reforms designed to promote high value care. Additional analyses are forthcoming, which will influence the committee's deliberations. These analyses include an exploration of how Medicare Part C (Medicare Advantage) and commercial spending, utilization, and quality vary compared with, and possibly are influenced by, Medicare Parts A and B spending, utilization, and quality. The committee also is assessing potential biases that may be inherent to Medicare and commercial claims-based measures of health status. Based on this new evidence and continued review of the literature, the committee will confirm the accuracy of the observations presented in this interim report and develop final conclusions and recommendations, which will be published in the committee's final report"--Publisher's description.
500 $aErrata sheet inserted.
504 $aIncludes bibliographical references (pages 31-34).
505 0 $aResearch framework and statistical modeling approach -- Geography and indexing value -- Evaluation of a geographic value index -- Contributors to geographic variation in Medicare spending -- Discussion -- Limitations.
650 0 $aMedicare$vStatistics.
650 0 $aMedicare$xFinance.
650 0 $aMedical care, Cost of$zUnited States.
650 0 $aHealth care reform$zUnited States.
700 1 $aNewhouse, Joseph P.,$eeditor.
776 08 $iAlso available online:$dWashington, D.C. : National Academies Press, 2012.$w(OCoLC)832726688
852 00 $boff,sci$hRA412.3$i.I565 2013g